New Opportunity For CER As Placebo Trials Show Shrinking Drug Efficacy Margins – Health Affairs
Executive Summary
Authors of a Health Affairs article find the effect of active drugs versus placebo has declined in controlled trials over time, suggesting to them that more attention should be focused on understanding the clinical value of existing treatments, including establishing equivalence of efficacy and focusing on differences in safety, cost and tolerability.